The short answer

No. Ozempic and Mounjaro are not part of the $50 Medicare GLP-1 Bridge. The Bridge only covers medicines approved for weight loss — Wegovy, Foundayo, and the Zepbound KwikPen. Ozempic and Mounjaro are approved to treat type 2 diabetes, so they sit outside the Bridge. If you take one for diabetes, your regular Medicare Part D plan may still cover it the same way it always has.

Why Ozempic and Mounjaro are left out

The Medicare GLP-1 Bridge, which runs from July 1, 2026 through December 31, 2027, was built for one purpose: to help people with obesity afford a weight-loss GLP-1 for a flat $50 a month. The U.S. Centers for Medicare & Medicaid Services (CMS) limited it to drugs that carry an FDA weight-loss approval.

Ozempic (semaglutide) and Mounjaro (tirzepatide) are approved to treat type 2 diabetes, not obesity. That single fact is why they are not in the Bridge — even though they are the same kind of drug and, in some cases, the very same molecule as the ones that are covered.

The same drugs have a weight-loss twin

This is the part that confuses almost everyone, so it is worth saying plainly:

  • Ozempic and Wegovy are both semaglutide. Ozempic is the diabetes version; Wegovy is the weight-loss version. Wegovy is in the Bridge. Ozempic is not.
  • Mounjaro and Zepbound are both tirzepatide. Mounjaro is the diabetes version; Zepbound is the weight-loss version. The Zepbound KwikPen is in the Bridge. Mounjaro is not.

So if your goal is weight loss, the covered "twin" of your drug may be an option — but only your prescriber can decide whether switching is right for you.

What the $50 Bridge actually covers

The Bridge covers these weight-loss medicines for the flat $50 monthly copay:

  • Wegovy — both the injection and the oral (pill) form
  • Foundayo — the oral tablet
  • Zepbound KwikPen — the weekly injection pen

That is the complete list. For a fuller breakdown, see which GLP-1 drugs the $50 Bridge covers and how the Bridge compares with Ozempic, Wegovy, and Zepbound.

If you take Ozempic or Mounjaro for diabetes

Good news: the Bridge changes nothing for you. If your doctor prescribes Ozempic or Mounjaro to manage type 2 diabetes, your Part D plan can keep covering it under its normal rules and your normal copay or coinsurance. You do not lose any coverage because of the Bridge.

What the Bridge does not do is give you that diabetes drug for $50. For the specifics, read does Medicare cover Ozempic? and does Medicare cover Mounjaro?.

Can you get a weight-loss GLP-1 instead?

If you have obesity — or a lower BMI plus a qualifying condition such as heart disease, prediabetes, or chronic kidney disease — you may qualify for a covered weight-loss drug through the Bridge. Eligibility starts at a BMI of 35, or a BMI of 30 with certain heart or kidney conditions, or a BMI of 27 with conditions like prediabetes or a prior heart attack or stroke.

Not sure where you land? Our free eligibility quiz walks you through it in a couple of minutes, and do you qualify for the $50 Bridge? explains the rules in detail.

What the $50 copay really means

For a covered drug, you pay a flat $50 per month — it does not rise as your dose increases. But two things surprise people: the $50 does not count toward your Part D deductible, and it does not count toward the annual $2,100 out-of-pocket drug cap (2026). See how much the Bridge costs for the full picture.

How to get a covered drug

You do not "enroll" in the Bridge. Instead, your doctor submits a prior authorization showing you are being prescribed a weight-loss GLP-1 and meet the criteria. CMS aims to turn requests around within 72 hours. Start with how to get the Medicare GLP-1 Bridge and GLP-1 prior authorization on Medicare.

Data as of June 2026, based on CMS and KFF guidance for the Medicare GLP-1 Bridge (July 1, 2026–December 31, 2027). Confirm current rules with your plan or Medicare.gov. This is general information, not medical advice — talk with your doctor before changing any medication.